All Articles tagged biosimilar
- Gastrointestinal Conditions
November 20, 2023 EDT This study describes persistence and dose titration among patients with Crohn's disease with 3 years of follow-up. Patients initiating ustekinumab had the highest persistence rate and lowest dose escalation rate.
- Methodology and Healthcare Policy
February 03, 2022 EDT The purpose of this study is to investigate the impact of generic/biosimilar entry on drug budgets in different country settings.